At the news
? BEARISHIMPACT 4/10 COURT-RULING filed Jul 30, 2026 at 20:00 ET
The Federal Circuit affirmed the PTAB's denial of Pfizer's motion to amend claims in its pneumococcal vaccine patent (U.S. Patent 9,492,559), holding that proposed substitute claims covering additional serotypes (15B, 33F, 12F, 10A, 11A, 8) would have been obvious. This is an adverse ruling for Pfizer, limiting its ability to broaden patent protection for its pneumococcal vaccine franchise, but the nonprecedential nature and lack of financial quantification make the material impact limited.
- Federal Circuit affirmed PTAB's denial of Pfizer's motion to amend claims 48 and 49 of U.S. Patent 9,492,559 for pneumococcal vaccine compositions.
- The court found substantial evidence supported obviousness of proposed substitute claims covering serotypes 15B, 33F, 12F, 10A, 11A, and 8.
- The ruling is nonprecedential and appears to be a final affirmance with low likelihood of further Supreme Court review.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access